AVICANNA INC (AVCN.CA) Stock Price, Quote, News and Overview
TSX:AVCN - Toronto Stock Exchange - CA05368K1003 - Common Stock - Currency: CAD
AVCN.CA Quote, Performance and Key Statistics
TSX:AVCN (3/7/2025, 7:00:00 PM)
0.37
+0.03 (+7.25%)
The current stock price of AVCN.CA is 0.37 CAD. In the past month the price increased by 27.59%. In the past year, price decreased by -23.71%.
AVCN.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.87 | 3.77B | ||
| CRON.CA | CRONOS GROUP INC | N/A | 1.08B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 928.28M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 4.93 | 675.16M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 546.47M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 3.62 | 495.53M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 376.34M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 293.01M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 12.54 | 288.91M | ||
| HITI.CA | HIGH TIDE INC | N/A | 278.36M | ||
| TSND.CA | TERRASCEND CORP | N/A | 249.63M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 198.02M |
Related stock screener links
About AVCN.CA
Company Profile
Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario and currently employs 38 full-time employees. The company went IPO on 2019-07-18. The firm's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.
Company Info
AVICANNA INC
480 University Avenue, Suite 1502
TORONTO ONTARIO M5G 1V2 CA
CEO: Aras Azadian
Employees: 87
Company Website: https://avicanna.com/
Investor Relations: http://ir.avicanna.com/ir/financial-documents/
Phone: 16472435283
AVICANNA INC / AVCN.CA FAQ
What is the stock price of AVICANNA INC today?
The current stock price of AVCN.CA is 0.37 CAD. The price increased by 7.25% in the last trading session.
What is the ticker symbol for AVICANNA INC stock?
The exchange symbol of AVICANNA INC is AVCN and it is listed on the Toronto Stock Exchange exchange.
On which exchange is AVCN.CA stock listed?
AVCN.CA stock is listed on the Toronto Stock Exchange exchange.
What is AVICANNA INC worth?
AVICANNA INC (AVCN.CA) has a market capitalization of 40.78M CAD. This makes AVCN.CA a Nano Cap stock.
How many employees does AVICANNA INC have?
AVICANNA INC (AVCN.CA) currently has 87 employees.
What are the support and resistance levels for AVICANNA INC (AVCN.CA) stock?
AVICANNA INC (AVCN.CA) has a support level at 0.23 and a resistance level at 0.41. Check the full technical report for a detailed analysis of AVCN.CA support and resistance levels.
Should I buy AVICANNA INC (AVCN.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AVCN.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AVCN.CA, evaluating the profitability, health, valuation and growth aspects
- AVICANNA INC (AVCN.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AVICANNA INC (AVCN.CA) Sales and EPS estimates to see what analysts future expectations are.
- AVICANNA INC (AVCN.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AVICANNA INC (AVCN.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AVICANNA INC (AVCN.CA) Stock Chart to make your own analysis
- AVICANNA INC (AVCN.CA) Latest news and press-releases to stay up to date.
Does AVICANNA INC (AVCN.CA) stock pay dividends?
AVCN.CA does not pay a dividend.
When does AVICANNA INC (AVCN.CA) report earnings?
AVICANNA INC (AVCN.CA) will report earnings on 2025-03-28, after the market close.
What is the Price/Earnings (PE) ratio of AVICANNA INC (AVCN.CA)?
AVICANNA INC (AVCN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
AVCN.CA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AVCN.CA. When comparing the yearly performance of all stocks, AVCN.CA is a bad performer in the overall market: 67.05% of all stocks are doing better.
AVCN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA. AVCN.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AVCN.CA Financial Highlights
Over the last trailing twelve months AVCN.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS increased by 52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.22% | ||
| ROE | -396.25% | ||
| Debt/Equity | 0 |
AVCN.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 40% to AVCN.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.